Introduction to Primary Bone Sarcomas
The evolution of orthopedic oncology over the past four decades has been defined by a paradigm shift from routine amputation to sophisticated limb-salvage surgery. This transformation is heavily predicated on advancements in neoadjuvant chemotherapy, advanced cross-sectional imaging (MRI), and modular endoprosthetic reconstruction.
The two most prevalent primary malignant bone tumors encountered by the orthopedic surgeon are osteosarcoma and chondrosarcoma. While both require meticulous surgical planning and precise execution of wide en bloc resection, their biological behaviors, responses to systemic therapy, and patient demographics differ profoundly. This masterclass synthesizes the foundational literature and modern operative principles required for the successful management of these aggressive neoplasms.
Part I: Osteosarcoma
Osteosarcoma is the most common primary malignant bone tumor in children and young adults, characterized by the production of malignant osteoid by spindle cells. The standard of care involves a tripartite approach: neoadjuvant chemotherapy, wide surgical resection, and adjuvant chemotherapy.
Pathophysiology and Histologic Variants
Understanding the histologic subtype is critical for surgical planning, as it dictates the biological aggressiveness and the required surgical margins.
- Conventional Osteosarcoma: Represents 75% of cases. Typically intramedullary, high-grade, and located in the metaphysis of long bones (distal femur, proximal tibia, proximal humerus).
- Telangiectatic Osteosarcoma: Lytic, destructive lesions with blood-filled spaces. Often confused radiographically with aneurysmal bone cysts (ABCs). Highly aggressive but highly responsive to chemotherapy.
- Parosteal Osteosarcoma: A low-grade surface variant, classically arising on the posterior aspect of the distal femur. Carries an excellent prognosis with wide surgical resection alone.
- Periosteal Osteosarcoma: An intermediate-grade surface lesion, typically diaphyseal, with a prominent cartilaginous component.
- Secondary Osteosarcoma: Arises in older adults secondary to Paget’s disease or prior radiation therapy. Carries a significantly poorer prognosis due to resistance to standard chemotherapy protocols.
Clinical Pearl: The histologic response to neoadjuvant chemotherapy (assessed via the Huvos grading system) is the single most important prognostic factor in conventional osteosarcoma. Tumor necrosis >90% indicates a favorable response.
Preoperative Workup and Surgical Indications
The goal of surgery is complete extirpation of the tumor with negative margins (R0 resection) while maximizing the functional utility of the limb.
Indications for Limb Salvage:
* Ability to achieve wide surgical margins.
* Preservation of major neurovascular bundles.
* Adequate soft tissue coverage available (either primary or via free flap transfer).
* A functional reconstructed limb that will be superior to a prosthesis.
Indications for Amputation:
* Major neurovascular involvement that cannot be bypassed or reconstructed.
* Extensive soft tissue contamination from a poorly placed prior biopsy.
* Infection at the tumor site.
* Pathologic fracture with massive hematoma tracking through fascial compartments (though modern protocols increasingly allow for limb salvage in select pathologic fractures if wide margins can still be achieved).
Surgical Principles and Step-by-Step Approach
1. Positioning and Preparation
- The patient is positioned based on the anatomic location (e.g., supine for distal femur, lateral decubitus for proximal femur or pelvis).
- A tourniquet may be applied but is not exsanguinated with an Esmarch bandage to prevent tumor embolization. Instead, the limb is elevated for 3 minutes prior to inflation.
- The entire limb must be prepped and draped free to allow for intraoperative manipulation and assessment of joint motion post-reconstruction.
2. The Incision and Biopsy Tract Excision
- The surgical incision must incorporate the previous biopsy tract.
- The biopsy tract is excised en bloc with the tumor specimen, maintaining a 1 to 2 cm cuff of normal skin and subcutaneous tissue around the scar.
3. Extracapsular Dissection
- Dissection must proceed through normal, unreactive tissue planes. The tumor pseudocapsule must never be visualized directly; seeing the tumor means the margin has been breached.
- Major neurovascular structures are identified proximally and distally in normal tissue, then carefully traced and skeletonized away from the tumor mass. If the adventitia is involved, the vessel must be resected and reconstructed with a reversed saphenous vein graft.
4. Osteotomy and Margin Assessment
- Preoperative MRI (T1-weighted coronal and sagittal sequences) is utilized to determine the intramedullary extent of the tumor.
- The osteotomy is planned at least 3 cm beyond the MRI-defined intramedullary extent of the tumor.
- Intraoperative frozen sections of the marrow margin must be sent to pathology to confirm the absence of microscopic disease before proceeding with reconstruction.
Surgical Warning: Always evaluate the preoperative MRI for skip metastases (distinct tumor foci within the same bone, separated by normal marrow). Failure to identify a skip metastasis will result in an intralesional resection and catastrophic local recurrence.
Reconstructive Options
Following wide resection, the resulting massive skeletal defect must be reconstructed.
- Modular Endoprosthesis (Megaprosthesis): The workhorse of modern limb salvage. Allows for immediate weight-bearing and rapid return to adjuvant chemotherapy. Biomechanical considerations include stem fixation (cemented vs. press-fit) and the use of rotating-hinge knee mechanisms to dissipate torsional forces.
- Osteoarticular Allograft: Biological reconstruction. High rates of non-union, infection, and late fracture, but preserves bone stock for future revisions.
- Allograft-Prosthetic Composite (APC): Combines the biological soft-tissue attachment advantages of an allograft with the articular durability of a prosthesis. Frequently used in the proximal femur and proximal humerus.
- Rotationplasty (Van Nes): An intercalary resection of the knee joint with 180-degree external rotation of the distal limb and reattachment to the proximal femur. The ankle joint functions as a knee joint. Highly durable, excellent for young children with significant remaining growth, avoiding the complications of expandable prostheses.
Part II: Chondrosarcoma
Unlike osteosarcoma, chondrosarcoma is a malignancy of adulthood (typically 40–70 years of age) characterized by the production of malignant hyaline cartilage. Because conventional chondrosarcoma is notoriously resistant to both chemotherapy and radiotherapy, surgical resection is the sole curative modality.
Pathophysiology and Classification
- Conventional Chondrosarcoma: Divided into Grades 1, 2, and 3. Grade 1 (Atypical Cartilaginous Tumor) is locally aggressive but rarely metastasizes. Grades 2 and 3 have high metastatic potential.
- Dedifferentiated Chondrosarcoma: A highly lethal variant where a low-grade chondrosarcoma abruptly transitions into a high-grade, non-cartilaginous sarcoma (e.g., osteosarcoma or malignant fibrous histiocytoma). Prognosis is dismal, requiring aggressive wide resection and systemic therapy.
- Clear Cell Chondrosarcoma: A rare, low-grade variant that uniquely involves the epiphysis (mimicking a chondroblastoma).
- Mesenchymal Chondrosarcoma: A highly cellular, aggressive variant that, unlike conventional types, may respond to chemotherapy and radiation.
Surgical Indications and Approaches
The surgical approach is strictly dictated by the histologic grade and anatomic location.
Management of Low-Grade (Grade 1) Chondrosarcoma
For Grade 1 lesions (Atypical Cartilaginous Tumors) confined to the intramedullary canal of long bones, wide en bloc resection is often considered overtreatment.
* Procedure: Extended intralesional curettage.
* Technique: A large cortical window is created. The cartilaginous tumor is meticulously curetted.
* Adjuvant Treatment: The cavity is treated with high-speed burring to extend the margin mechanically, followed by chemical or thermal adjuvants (phenol, liquid nitrogen, or argon beam coagulation) to eradicate microscopic disease.
* Reconstruction: The defect is packed with polymethylmethacrylate (PMMA) bone cement, which provides immediate structural stability and a thermal necrotic effect during polymerization.
Management of High-Grade and Dedifferentiated Chondrosarcoma
Grades 2, 3, and dedifferentiated variants demand aggressive wide en bloc resection, identical in principle to the management of osteosarcoma.
Pitfall: Cartilage tumors are highly prone to seeding. If the tumor capsule is breached during resection, the risk of local recurrence approaches 100%. Meticulous hemostasis and strict adherence to wide margins are non-negotiable.
Pelvic Chondrosarcoma: Special Considerations
The pelvis is a common site for chondrosarcoma. Pelvic resections (internal hemipelvectomies) are technically demanding due to complex anatomy and proximity to visceral and neurovascular structures. Resections are classified by the Enneking and Dunham system:
* Type I (Iliac): Resection of the ilium. Reconstruction may involve pelvic allografts or custom 3D-printed implants, though flail hip (no reconstruction) is often well-tolerated.
* Type II (Periacetabular): Resection of the acetabulum. This is the most functionally debilitating. Reconstruction options include saddle prostheses, custom triflange cups, or ischiofemoral arthrodesis.
* Type III (Pubis/Ischium): Resection of the anterior ring. Rarely requires reconstruction as the weight-bearing axis is preserved.
* Type IV (Sacral): En bloc sacrectomy.
Postoperative Protocols and Rehabilitation
The postoperative management of bone sarcoma patients requires a delicate balance between aggressive rehabilitation and the protection of complex reconstructions.
Immediate Postoperative Care
- VTE Prophylaxis: Oncology patients are at a profoundly elevated risk for venous thromboembolism. Chemical prophylaxis (LMWH) is initiated postoperatively and continued for 4 to 6 weeks.
- Antibiotic Prophylaxis: Due to the massive dead space and use of bulk foreign materials (megaprostheses/allografts), prophylactic IV antibiotics (typically a first-generation cephalosporin) are continued until surgical drains are removed.
- Wound Healing: Chemotherapy impairs wound healing. Sutures or staples should remain in place for a minimum of 3 to 4 weeks.
Weight-Bearing and Mobilization
- Cemented Endoprostheses: Allow for immediate weight-bearing as tolerated. Early mobilization is critical to prevent arthrofibrosis, particularly in distal femoral replacements.
- Allografts and APCs: Require restricted weight-bearing (toe-touch or partial) for 3 to 6 months until radiographic evidence of host-allograft junctional healing is observed.
- Intralesional Curettage (with PMMA): Immediate weight-bearing is permitted, as the cement provides maximal compressive strength immediately upon curing.
Complications and Oncologic Surveillance
Surgical Complications
- Infection: The Achilles heel of orthopedic oncology. Deep periprosthetic joint infections (PJI) in megaprostheses occur in 10-15% of cases. Management requires a two-stage revision with an antibiotic spacer. Amputation may be required for recalcitrant infections.
- Aseptic Loosening: The most common long-term complication of endoprosthetic reconstruction, necessitating revision surgery.
- Structural Failure: Fracture of the allograft or breakage of the prosthetic stem, often related to the altered biomechanics of the reconstructed limb.
Oncologic Surveillance
Long-term surveillance is mandatory to detect local recurrence and distant metastasis. The lungs are the most common site of metastasis for both osteosarcoma and chondrosarcoma.
* Protocol: Physical examination, radiographs of the reconstructed limb, and non-contrast CT of the chest every 3 months for the first 2 years, every 6 months for years 3 to 5, and annually thereafter.
* Metastasectomy: In osteosarcoma, the development of pulmonary metastases is not a death sentence. Aggressive surgical resection (thoracotomy and wedge resection) of pulmonary nodules has been shown to significantly improve long-term survival.
